Once upon a time a big success for Antisense would have been significant for Opthea - they used to hold a larger fraction of the company, and the two companies had vaguely similar market caps. But now ANP could triple in value and that'd be worth barely $1 million to Opthea - of no real consequence for a company with $30 million in cash and a market cap approaching $1 billion.
More interesting would be if Opthea could now look at some of the other IP assets it inherited from its life as Circadian...
Once upon a time a big success for Antisense would have been...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.040(4.57%) |
Mkt cap ! $1.126B | |||
| Open | High | Low | Value | Volume |
| 91.0¢ | 92.0¢ | 88.5¢ | $3.082M | 3.401M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27049 | 90.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 10000 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |